Skip to main content
. 2019 Apr 15;9:6103. doi: 10.1038/s41598-019-42468-4

Table 1.

Characteristics at baseline.

Total (n = 60) Responders (n = 38) Non-responders (n = 22) p value
Age(year) 69 ± 10 68 ± 10 69 ± 10 0.820
Female sex 15%(9) 18%(7) 9%,(2) 0.464
BMI(kg/m²) 28 ± 5 27 ± 5 29 ± 5 0.281
Hypertension 55%(33) 58%(22) 50%(11) 0.561
Dyslipidemia 62%(37) 55%(21) 73%(16) 0.186
Obesity 32%(19) 29%(11) 36%(8) 0.560
Diabetes mellitus 28%(17) 21%(8) 41%(9) 0.103
History of Heart Failure 55%(33) 50%(19) 64%(14) 0.314
Chronic Respiratory Insufficiency 15%(9) 5%(2) 32%(7) 0.006
Denutrition 3%(2) NA 9%(2) 0.060
Non-ischemic cardiomyopathy 42%(25) 55%(21) 18%(4) 0.005
IHM 45%(27) 29%(11) 73%(16) 0.001
Heart Rate(bpm) 68 ± 11 66 ± 10 71 ± 13 0.140
NYHA 2.41 ± 0.65 2.16 ± 0.68 2.25 ± 0.59 0.153
6MWT(m) 365 ± 167 385 ± 187 326 ± 116 0.216
MLWHFQ 32 ± 18 29 ± 18 39 ± 15 0.031
QRS duration(ms) 163 ± 24 172 ± 22 147 ± 19  < 0.001
  LBBB 52%(31) 63%(24) 32%(7) 0.019
  NICD 27%(16) 13%(5) 50%(11) 0.002
  RBBB 5%(3) 3%(1) 9%(2) 0.276
  Paced 17%(10) 21%(8) 9%(2) 0.238
Estimated GFR(/ml/min/1.73 m²) 69.1 ± 24.6 71.8 ± 24.5 64.5 ± 24.8 0.272
NT-ProBNP(ng/dl) 3547 ± 8492 2753 ± 4558 4919 ± 12764 0.345
Heart Failure Drugs
  Beta-blockers 80%(47) 81%(30) 77%(17) 0.750
  ACEi/ARBs 82%(49) 84%(32) 77%(17) 0.512
  MRA 37%(22) 34%(13) 41%(9) 0.600
  Ivabradine 17%(10) 16%(6) 18%(4) 0.849
  Loop diuretics 80%(48) 76%(29) 86%(19) 0.510
Echocardiography
  Indexed end-diastolic volume(ml/m²) 99 ± 25 91 ± 17 104 ± 28 0.049
  Indexed end-systolic volume(ml/m²) 71 ± 21 64 ± 17 75 ± 22 0.041
  LVEF(%) 28 ± 6 29 ± 7 28 ± 6 0.660
  PAPs(mmHg) 34 ± 12 28 ± 9 40 ± 13 0.003
LV Lateral lead position 82%(49) 89%(34) 68%(15) 0.040
CRT-D 80%(48) 79%(30) 82%(18) 0.118

6MWT = Six-minute walking test; ACEi = Angiotensin-converting enzyme inhibitor; ARBs = angiotensin receptor blockers; BMI = Body mass index;; eGFR = estimated glomerular filtration rate; IHM = Ischemic heart disease; LBBB = Left bundle branch block; LVEF = left ventricular ejection fraction; MLWHFQ = Minnesota Living With Heart Failure Questionnaire; MRA = Mineralocorticoid antagonist receptor; NICD = Non-specific intraventricular conduction delay; NYHA = New York Heart Association; PAPs = Pulmonary arterial pressure; RBBB = Right bundle branch block.